for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Lilly asks FDA to revoke authorization for COVID-19 antibody bamlanivimab alone

April 16 (Reuters) - Eli Lilly and Co said on Friday it had requested the U.S. Food and Drug Administration to revoke the emergency use authorization granted to its COVID-19 antibody bamlanivimab alone due to the full availability of its combination therapy. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Amy Caren Daniel)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up